New research indicates that individuals who discontinue popular slimming jabs like semaglutide or tirzepatide tend to recover reduced body mass much more quickly than those who halt traditional diet and exercise regimens.
Published data in a major health publication shows that while overweight people often shed substantial amounts of their body weight while on the medication, the mass returns at an average rate of 0.8 kg per month once they quit.
"People purchasing these medications should be aware of the risk of quick weight regain when the therapy is stopped," stated lead investigator Dr. Susan Jebb.
This pace of regain implies a reversion to original mass in about a year and a half.
Weighing Therapies
The study, which examined dozens of trials involving over 9,000 of patients, compared the outcomes of GLP-1 agonists with older methods.
Scientists note that individuals who shed pounds through dieting usually have a slower weight regain—around 100 grams monthly—once they finish.
The Reason for the Quick Regain
Doctors suggest the mechanism of the injections is key to understanding the amplified rebound.
These medications copy a body's own chemical called glucagon-like peptide-1, which helps regulate hunger.
"Long-term administration of GLP-1 levels several times higher than the body's typical production may cause the body to generate a reduced amount of its endogenous hormone, and could diminish responsiveness to its actions," explained Dr. Adam Collins, a nutrition expert.
"Withdrawal of this medication leads to appetite is unsuppressed, making excessive eating much more probable."
A Chronic Condition?
Medical guidelines advise the jabs for people with weight-linked health risks, accompanied by prescribed diet and exercise modifications.
Many experts say that, given the high risk of weight regain, the therapy might need to be long-term.
This opinion is reinforced by pharmaceutical companies, who state that the findings "highlight the chronic nature of excess weight," comparing it to managing diseases like high blood pressure.
Patient Testimonies
Users who have discontinued the medication report a powerful resurgence of cravings.
"It was like a trigger that goes on and you're instantly ravenous," said an individual.
This difficulty is worsened if individuals have not established lasting lifestyle or habit changes during treatment.
Significant Use
Survey data show that millions of people in the UK have tried weight-loss jabs in the past year, with demand remaining high.
- Use is more common among women than men.
- The 40s and 50s demographic shows the highest usage rates.
- Many obtain the medications through private healthcare rather than public health services.
In conclusion, clinicians emphasize that while these medications are powerful agents for shedding pounds, they are not a standalone solution and lasting health benefits relies on combined lifestyle management.
